Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |